Ossiam boosted its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 4,274.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 209,052 shares of the company's stock after buying an additional 204,273 shares during the period. Ossiam's holdings in Corteva were worth $11,908,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of CTVA. Capital World Investors increased its holdings in shares of Corteva by 2,874.6% during the fourth quarter. Capital World Investors now owns 12,812,151 shares of the company's stock valued at $729,780,000 after purchasing an additional 12,381,436 shares during the period. Independent Franchise Partners LLP grew its position in Corteva by 51.5% in the 4th quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company's stock valued at $939,641,000 after buying an additional 5,604,838 shares in the last quarter. Norges Bank acquired a new position in Corteva during the 4th quarter valued at about $251,892,000. Raymond James Financial Inc. bought a new stake in shares of Corteva during the 4th quarter worth about $161,052,000. Finally, Franklin Resources Inc. raised its position in shares of Corteva by 9.2% during the 4th quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company's stock worth $919,507,000 after buying an additional 1,354,418 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.
Insider Activity
In related news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company's stock, valued at approximately $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.14% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts recently commented on CTVA shares. Citigroup raised their price objective on shares of Corteva from $69.00 to $74.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Bank of America boosted their price objective on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. Royal Bank of Canada raised their target price on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. BNP Paribas upgraded shares of Corteva to a "hold" rating in a research report on Monday, February 10th. Finally, Barclays raised their price objective on shares of Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a research report on Tuesday, January 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Corteva has a consensus rating of "Moderate Buy" and an average target price of $68.13.
Read Our Latest Stock Report on CTVA
Corteva Stock Up 1.1 %
Shares of CTVA stock traded up $0.64 during trading on Thursday, hitting $61.71. 1,834,465 shares of the company were exchanged, compared to its average volume of 3,307,839. The firm has a market capitalization of $42.15 billion, a price-to-earnings ratio of 47.83, a P/E/G ratio of 1.68 and a beta of 0.73. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. The business's 50-day simple moving average is $60.82 and its 200 day simple moving average is $60.32. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, analysts forecast that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva's dividend payout ratio (DPR) is presently 52.71%.
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also

Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.